Suanfarma Suanfarma

X

CAS 54142-64-2 manufacturers and suppliers on PharmaCompass

PharmaCompass
FLEHAOYBYPJWKG-SHQPEEILSA-N
Also known as: 54142-64-2, (3ar,4r,5r,6as)-2-oxo-4-((e)-3-oxo-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)hexahydro-2h-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate, Schembl5575196, Schembl5575212, Zinc8385724, Akos025402012
Molecular Formula
C31H25F3O6
Molecular Weight
550.5  g/mol
InChI Key
FLEHAOYBYPJWKG-SHQPEEILSA-N

1 2D Structure

FLEHAOYBYPJWKG-SHQPEEILSA-N

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(3aR,4R,5R,6aS)-2-oxo-4-[(E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-5-yl] 4-phenylbenzoate
2.1.2 InChI
InChI=1S/C31H25F3O6/c32-31(33,34)22-7-4-8-24(15-22)38-18-23(35)13-14-25-26-16-29(36)39-28(26)17-27(25)40-30(37)21-11-9-20(10-12-21)19-5-2-1-3-6-19/h1-15,25-28H,16-18H2/b14-13+/t25-,26-,27-,28+/m1/s1
2.1.3 InChI Key
FLEHAOYBYPJWKG-SHQPEEILSA-N
2.1.4 Canonical SMILES
C1C2C(CC(=O)O2)C(C1OC(=O)C3=CC=C(C=C3)C4=CC=CC=C4)C=CC(=O)COC5=CC=CC(=C5)C(F)(F)F
2.1.5 Isomeric SMILES
C1[C@H]2[C@H](CC(=O)O2)[C@H]([C@@H]1OC(=O)C3=CC=C(C=C3)C4=CC=CC=C4)/C=C/C(=O)COC5=CC=CC(=C5)C(F)(F)F
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 54142-64-2

2. (3ar,4r,5r,6as)-2-oxo-4-((e)-3-oxo-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)hexahydro-2h-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate

3. Schembl5575196

4. Schembl5575212

5. Zinc8385724

6. Akos025402012

7. [(3ar,4r,5r,6as)-2-oxo-4-[3-oxo-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-5-yl] 4-phenylbenzoate

8. Ac-28179

9. 142b642

10. A855006

11. J-501131

12. (1,1'-biphenyl)-4-carboxylic Acid,(3ar,4r,5r,6as)-hexahydro-2-oxo-4-((1e)-3-oxo-4-(3-(trifluoromethyl)phenoxy)-1-buten-1-yl)-2h-cyclopenta[b]furan-5-yl Ester

13. (3ar,4r,5r,6as)-2-oxo-4-((e)-3-oxo-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)hexahydro-2h-cyclopenta[b]furan-5-yl [1,1'-biphenyl]- 4-carboxylate

14. (3ar,4r,5r,6as)-2-oxo-4-((e)-3-oxo-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)hexahydro-2h-cyclopenta[b]furan-5-yl[1,1'-biphenyl]-4-carboxylate

15. (3ar,4r,5r,6as)-4-[3-oxo-4-[3-(trifluoromethyl)phenoxy]-1e-butenyl]-5-(4-phenylbenzoyloxy)-hexahydro-2h-cyclopenta[b]furan-2-one

16. [(3ar,4r,5r,6as)-2-oxo-4-[(e)-3-oxo-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-5-yl] 4-phenylbenzoate

2.3 Create Date
2006-11-06
3 Chemical and Physical Properties
Molecular Weight 550.5 g/mol
Molecular Formula C31H25F3O6
XLogP36.3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count9
Rotatable Bond Count9
Exact Mass550.16032300 g/mol
Monoisotopic Mass550.16032300 g/mol
Topological Polar Surface Area78.9 Ų
Heavy Atom Count40
Formal Charge0
Complexity934
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
53872-60-9
Travoprost
Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leader...
Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leadership of a “National 1000 Talents Program” expert. By leveraging its core competency in chiral synthesis, enzymatic catalysis and continuous flow micro reactor, HwaGen Pharmaceutical is dedicated to development and manufacturing of specialty and niche intermediates and APIs covering various therapeutic areas including oncology, antiviral and respiratory, delivering high value-added and affordable products for global pharmaceutical industry. Equipments for Analysis & Test include Tabletop NMR, LC-MS, GC, HPLC etc.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
54094-19-8
Travoprost
Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leader...
Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leadership of a “National 1000 Talents Program” expert. By leveraging its core competency in chiral synthesis, enzymatic catalysis and continuous flow micro reactor, HwaGen Pharmaceutical is dedicated to development and manufacturing of specialty and niche intermediates and APIs covering various therapeutic areas including oncology, antiviral and respiratory, delivering high value-added and affordable products for global pharmaceutical industry. Equipments for Analysis & Test include Tabletop NMR, LC-MS, GC, HPLC etc.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY